Background: This systematic review summarises association between short inter-
infections following a short interpregnancy interval.
1 A previous systematic review and meta-analysis found that an interpregnancy interval <6 months is associated with 40% higher odds of preterm birth, 61% higher odds of low birthweight and 26% higher odds of small-for-gestational age in the subsequent pregnancy.
2
Short interpregnancy intervals up to 17 months were also associated with greater risks for these outcomes. The applicability of the WHO recommendations to the United States is unclear because breast feeding, nutrition, age at first birth and parity differ between the United States and the lower-resource countries upon which most of the evidence reviewed for the WHO recommendation is based. [4] [5] [6] [7] Further, the evidence for the WHO recommendations does not include the findings of research conducted since 2006. Recent studies using maternally linked birth records and employing matched study design have found mostly null associations between short interpregnancy interval and adverse outcomes, [8] [9] [10] [11] prompting renewed concern that previously observed associations may be due to confounding.
12
The purpose of this systematic review is to summarise research on the associations between short interpregnancy intervals and adverse perinatal outcomes in high-resource settings. The association between short interpregnancy intervals and adverse maternal outcomes in high-resource settings is reported separately in this journal supplement. 13 Findings from this review can be used to inform evidence-based recommendations for healthy birth spacing for the United States. 14 At present, although short interpregnancy interval is a recognised risk factor for preterm birth and low birthweight, 15, 16 and the American College of Obstetricians and Gynecologists recommends women be advised to avoid interpregnancy intervals shorter than 6 months, 16 there are no federal recommendations on healthy birth spacing for the United States.
| ME THODS
This systematic review adhered to established methodological standards. 17, 18 Investigators developed an analytic framework outlining the target population and relationships between interpregnancy intervals and outcomes ( Figure S1 ). The key question guiding this systematic review was "In postpartum women in the
United States, what is the effect of short interpregnancy intervals (any interval <24 months) versus a longer interval on shortterm perinatal health outcomes: low birthweight, preterm birth, small-for-gestational age, intrauterine growth restriction, APGAR score, neonatal intensive care unit admission, stillbirth, neonatal mortality, infant mortality, and congenital anomaly?" In this study, we synthesise findings for the most commonly examined perinatal outcomes, including preterm birth, spontaneous preterm birth, small-for-gestational age, perinatal death and infant mortality. Although low birthweight was a commonly studied outcome, we did not synthesise the evidence for this outcome because its value as a health indicator is limited primarily to lower-resource settings where accurate estimates of gestational age are unavailable. 19 However, all relevant perinatal findings are presented in a supplemental table (Table S1 ).
The protocol (available upon request) is based on a previous systematic review published in 2006 on the effects of birth spacing on adverse perinatal outcomes. Twenty-nine studies were conducted on study populations from the United States and other high-resource countries, of which 19 examined interpregnancy intervals (as opposed to birth-to-birth intervals).
21-39

| Literature search
Using the same search terms as the 2006 review, 2 we conducted electronic searches of PubMed/Medline, POPLINE, EMBASE, CINAHL and the Cochrane Database of Systematic Reviews for relevant articles published between 1 January 2006 and 1 May 2017.
In addition to search terms for specific outcomes, we also included general terms, such as "perinatal outcome," "perinatal morbidity," "pregnancy outcome," "adverse outcome," "obstetric outcome" and "infant outcome." Specific search terms and publication date ranges are listed in Table S2 .
| Inclusion/exclusion criteria
Inclusion criteria for studies were developed a priori using the PICOTSS (population, intervention/exposure, comparison group, outcome, time, setting and study design) framework 40 and independently applied to the search results by two study authors (KAA and JAH) in a two-stage review process (Table S3) . 41 Studies from the 2006 review meeting new, more restrictive inclusion criteria were also included. Included studies met the following criteria:
1. The study population consisted of women of reproductive age with at least one livebirth who became pregnant again. Women whose last delivery was a stillbirth were also included, as long as they comprised <5% of the study population (ie, the cohort was not specifically drawn from women with a prior stillbirth).
2.
The study measured interpregnancy interval since last livebirth-defined as the interval between delivery of a birth (liveborn or stillborn) and start of the subsequent pregnancy (also known as birth-to-conception interval)-rather than other types of intervals (eg, post-abortion or post-pregnancy loss interpregnancy interval, birth-to-birth interval). This definition was imposed because there are separate recommendations for interpregnancy interval following pregnancy losses. 3 Further, birth-to-birth intervals are the sum of the interpregnancy interval and the duration of the subsequent pregnancy; therefore, women with adverse pregnancy outcomes associated with shorter pregnancy duration (such as stillbirth or preterm birth) will have systematically shorter birth-to-birth intervals than women without these outcomes. This systematic difference creates the potential for bias due to reverse causation (ie, a short birth-to-birth interval being the result of, rather than the cause of, an adverse outcome).
3.
The study compared a short interpregnancy interval, defined as any interval shorter than 24 months, to a longer interpregnancy interval (the reference interval). The reference interval had to F I G U R E 1 Literature flow diagram. *947 records include eight unique records identified from a targeted review conducted on September 22, 2017 to find articles on interpregnancy intervals and uterine rupture, placental abruption and placenta previa, which were outcomes relevant to the maternal outcomes systematic review Assessed at time of subsequent pregnancy: maternal age (3 levels), marital status, height, socio-economic deprivation category (5 levels), smoking, previous birthweight, previous caesarean section.
Married, nonsmokers, age ≥25
Good internal validity Strengths: use of hospital discharge records increased accuracy of diagnoses; controlled for detailed individual-level measure of socio-economic position, prior stillbirth or neonatal death and intervening pregnancy losses; adjusted for covariates at time of first, not second pregnancy.
Weaknesses: did not account for pregnancy intention. Good external validity: population-based sample from Scotland, UK.
Assessed at time of subsequent pregnancy: smoking status, maternal age (4 levels), education (2 levels), cohabitating with father, maternal country of birth, diabetes, hypertensive disease, year of delivery, outcome of first pregnancy.
None
Good internal validity
Strengths: data obtained from high-quality population birth registry linked with individual records on educational achievement and immigration status; accounted for prior stillbirth or neonatal death. Weaknesses: did not account for pregnancy intention or intervening losses; adjustment for covariates at time of second pregnancy such as maternal age may be an overadjustment. Good external validity: national population-based sample from Sweden.
Assessed at time of subsequent pregnancy: Preceding infant's birthweight, paternal acknowledgement, maternal age at delivery (6 levels), race, education (2 levels), adequacy of prenatal care utilisation, outcome of most recent pregnancy, smoking, alcohol.
Factors included as covariates and birth-order pair
Poor internal validity Strengths: large, population-based cohort.
Weaknesses: control for socio-economic position limited; did not control for pregnancy intention, prior neonatal death, or account for losses between pregnancies. Good external validity: population-based sample from Michigan.
Assessed at time of first delivery: preterm, small-for-gestational age/preeclampsia and caesarean section. Assessed at time of subsequent delivery: maternal age (6 levels), social deprivation category (7 levels), height, smoking, marital status.
Size for age at birth (small vs appropriate-forgestational age)
Fair internal validity
Strengths: large population-based sample; hospital discharge records increased accuracy; individual-level measure of socioeconomic position. Weaknesses: no adjustment for pregnancy intention or prior neonatal death; does not account for intervening miscarriages. Good external validity: population-based study from Scotland, UK.
Assessed at time of subsequent delivery: maternal age (3 levels), prepregnancy BMI, infant sex, height, parity, gestational age, smoking, alcohol, psychosocial stress, pregnancy intention, cohabitant status, education (3 levels), country of birth. Parity, education (4 levels), maternal age (y), year of birth, previous preterm birth.
Folic acid supplementation Fair internal validity
None
Good internal validity
Strengths: use of sibling comparison design to control for confounding by time-invariant characteristics. Weaknesses: did not control for risk factors such as smoking and pre-pregnancy BMI that vary between a woman's pregnancies. Poor external validity: limited to women with three or more births with discordant perinatal outcomes.
Assessed at time of subsequent delivery: birth year, child's sex, maternal age at delivery (6 levels); parity, adequacy of prenatal care, high school graduate (3 levels); received income assistance (3 levels); socio-economic index (6 levels), smoking, alcohol, substance use, chronic hypertension, maternal/ gestational diabetes, previous pregnancy losses or stillbirths, perinatal outcome of previous birth. have clearly defined lower and upper boundaries (ie, "18-23 months" rather than ">18 months"). Clearly defined boundaries were required because of the reverse J-shaped relationship between interpregnancy interval and many adverse perinatal outcomes. 36 Reference categories without an upper boundary can represent a heterogeneous risk group. For similar reasons, studies that modelled interpregnancy interval assuming a continuous, linear association with the adverse perinatal outcome were also excluded.
None
Good internal validity
4.
The study examined at least one of the following outcomes: preterm birth, small-for-gestational age, foetal death, perinatal death, neonatal death, infant death, low birthweight, intrauterine growth restriction, Apgar score, neonatal intensive care unit or congenital anomaly.
The study was published between 1 January 2006 and 1 May
2017.
6. The study was designed as a randomised controlled trial, cohort, cross-sectional or case-control study and could use unmatched (between-woman) or matched (within-sibling) designs. The study adjusted for maternal age and at a least one measure of socioeconomic position.
7.
The study included at least 100 individuals.
In addition, included studies were available as full-text Englishlanguage publications (ie, not an abstract from a conference presentation) and presented the relevant findings and estimates of precision numerically (eg, 95% confidence interval [CI] or standard error).
| Data abstraction, study quality assessment, data synthesis
A structured Excel-based abstraction form was developed for data abstraction (available on request). Two study authors independently abstracted relevant data from full-text articles of included studies; discrepancies were resolved through discussion. 41 Data included study design, source, setting, numbers and characteristics of participants, interpregnancy intervals, comparisons, adjustment for confounders, perinatal outcomes and results.
Included studies were assessed for internal and external study quality using criteria outlined by the U.S. Preventive Services Task
Force and rated as good, fair or poor. 42, 43 Two reviewers independently assessed quality and discrepancies were resolved through consensus. In a few instances, we contacted study authors to discuss study details needed for completing the quality assessment.
Internal validity was determined by evaluating sources of potential information bias (misclassification), confounding and selection bias. Assessments were guided by the key study design considerations identified by a recent Office of Population Affairs' expert work group reviewing the evidence on short birth spacing F I G U R E 2 A, Adjusted odds ratios and 95% confidence intervals for the association between interpregnancy interval and preterm birth among studies rated as having "good" internal validity from high-resource settings. Black solid circles indicate the reference category, and red solid circles indicate studies using a sibling comparison design; B, Adjusted odds ratios and 95% confidence intervals for the association between interpregnancy interval and preterm birth among studies rated as having "fair" internal validity from high-resource settings. Black solid circles indicate the reference category. Confidence intervals are not discernible for some studies because they fell within the range covered by the point estimate symbol (black hollow circle); C, Adjusted odds ratios and 95% confidence intervals for the association between interpregnancy interval and spontaneous preterm birth among studies from high-resource settings. Black solid circles indicate the reference category F I G U R E 3 Adjusted odds ratios and 95% confidence intervals for the association between interpregnancy interval and small for gestational age birth among studies from high-resource settings. Black solid circles indicate the reference category, red solid circles indicate studies using a sibling comparison design, and vertical dashed line separates studies with good internal validity from those with fair internal validity. Confidence intervals are not discernible for some studies because they fell within the range covered by the point estimate symbol (black hollow circle) and adverse pregnancy outcomes. 44 These included the extent to which the study incorporated a detailed measure of socioeconomic position, accounted for pregnancy intention, identified early pregnancy losses occurring between the last birth and the subsequent pregnancy being evaluated (which could result in differential misclassification of interpregnancy interval) and accounted for perinatal death (stillbirth or neonatal death) in the previous pregnancy.
44
External validity (generalisability) was determined by comparing the study population to either the general obstetric population in the United States or, for studies of women with specific obstetric history, a population with similar history in the United States.
Study design classification was based on when interpregnancy interval information was most likely documented in relation to when perinatal outcomes were assessed. As many of the studies were population-based samples of birth records, information on interpregnancy interval was assumed to originate from the prenatal medical record, which would have therefore been captured prior to the pregnancy outcome being known.
45
Consequently, population-based record samples were considered cohort studies.
Results of studies rated as having good or fair internal validity were qualitatively synthesised, taking into account both the magnitude and precision of relative risk estimates.
F I G U R E 4
A, Adjusted odds ratios and 95% confidence intervals for the association between interpregnancy interval and perinatal death among studies from high-resource settings. Black solid circles indicate the reference category, and vertical dashed line separates studies with good internal validity from those with fair internal validity; B, Adjusted odds ratios and 95% confidence intervals for the association between interpregnancy interval and infant death among studies from high-resource settings. Black solid circles indicate the reference category, and vertical dashed line separates studies with good internal validity from those with fair internal validity
TA B L E 2 Summary of evidence
Outcome Studies (k) Study designs Observations (n)
Summary of findings
Consistency and precision
Other limitations
Strength of evidence Applicability
Preterm birth 14 studies (cohort); N = 2 557 668 Risk was significantly higher with shorter IPI in 10 studies (aOR ≥ 1.20 for ~<6 mo in 10 studies, but only four of six good-quality studies; point estimates decreased with increasing IPI). 12-17 mo in 1 study).
Consistent, precise Few studies; variation in outcome definition, limited adjustment for confounders, and validity of US vital statistics-based data sources.
Moderate
Moderate IPI, interpregnancy interval; aOR, adjusted odds ratio. The 32 included studies are described in Table 1 . 63 Most studies had large sample sizes (only two studies had sample size <3000 10,62 and the largest study was 847 618 individuals 47 ), and over half of studies (n = 17) used 18-23 months as the interpregnancy interval reference group for analyses (Table 1) . One study was a case-control study, 54 and the rest were cohort studies, which included four studies with interview data. [27] [28] [29] 52 No studies evaluated the effects of an intervention designed to reduce short interpregnancy intervals on subsequent perinatal outcomes. Most studies evaluated more than one perinatal outcome.
| RE SULTS
Nine of the 32 studies met criteria for good internal validity, (Table 1) . Most studies included a limited set of covariates for adjustment, and no study accounted for all the study design considerations outlined above. However, previous pregnancy stillbirth or neonatal death was accounted for in eight studies, 9, [35] [36] [37] [38] 46, 50, 60 pregnancy intention was measured in two studies, 28, 52 and intervening pregnancy loss was accounted for-usually in the study cohort definition-in seven studies. 10, 21, 28, 29, 49, 55, 56 Generally, studies rated as good-quality accounted for a measure of socio-economic position beyond maternal education (the primary socio-economic measure on the U.S. birth certificate), in addition to at least one of the key study design considerations listed above. These higher quality studies included four studies that used a matched (within-sibling comparison) design, [8] [9] [10] [11] which controls for time-fixed confounders by using a woman as her own control.
Studies rated as poor-quality generally adjusted for only a single binary measure of socio-economic position, usually maternal education. All studies, except one, 27 included adjustment for covariates measured during or after the end of the interpregnancy interval, which can introduce overadjustment bias if these covariates operate as causal intermediates. 64 Most studies found attenuated estimates after adjustment for covariates, but the magnitude of that attenuation varied by perinatal outcome, length of interpregnancy interval and covariate adjustment set; generally, the shortest interpregnancy intervals evaluated showed the greatest attenuation after adjustment (Table S1 ). In the light of the potential for residual confounding and overadjustment bias, statistical meta-analysis was not performed and results were synthesised qualitatively.
Most studies (n = 19) were rated as having good external validity, reflecting the common use of population-based data (including birth certificate records and population perinatal registries). Eight studies met criteria for fair-quality 25, [27] [28] [29] 52, 55, 61, 62 and five for poor. [8] [9] [10] [11] 48 The eight studies meeting criteria for fair-quality 25, [27] [28] [29] 52, 55, 61, 62 were limited by including populations from only a single hospital or county; 28, 29, 55 including Healthy Start Program participants and matched controls from selected counties; 62 excluding certain race/ ethnicity groups 25 ; having low participation or follow-up rates 27, 52 or taking place in settings with markedly different access to reproductive health services compared to the United States. 61 The five poor-quality studies [8] [9] [10] [11] 48 included four matched studies, which, by design, were restricted to women with three or more pregnancies and discordant pregnancy outcomes. [8] [9] [10] [11] The other poor-quality study included only hospital births delivered by gynaecologists in the Netherlands, 48 which represents higher risk pregnancies compared to those among women delivered in other settings in that country.
| Preterm birth
Preterm birth (defined as <37 weeks' gestation) was assessed in 14 cohort studies (Figure 2A,B) . Among the six good-quality studies (Figure 2A ), [8] [9] [10] [11] 22, 46 46 The remaining aOR estimates from these studies were smaller in magnitude or not statistically significant.
Among the eight fair-quality studies ( Figure 2B ), all reported statistically significant aORs for the shortest interpregnancy interval examined in each study. 21, 36, 37, [47] [48] [49] [50] [51] Six of these studies found significant associations for <6-month interpregnancy intervals (estimates ranged in magnitude from an aOR = 1. The good-quality studies usually reported lower estimates for a given interpregnancy interval compared with fair-quality studies. Generally, for all studies, the shorter the interpregnancy interval, the higher the reported estimate.
| Spontaneous preterm birth
Spontaneous preterm birth was assessed in two good-quality cohort studies ( Figure 2C) . 28, 46 Odds ratios were significantly higher with shorter intervals in one study (aOR = 
| Small-for-gestational age
Small-for-gestational age (defined as <10th percentile) was assessed in 11 cohort studies; eight studies used external weight-forgestational age charts to define small-for-gestational age, one used an internally derived chart, and in two studies, the choice of charts was not stated (Figures 3 and S1 ). Among the four good-quality studies, [8] [9] [10] 46 interpregnancy intervals <6, 6-11 or 12-17 months
were associated with increased risks in one study, although the magnitude of increased risk was small (eg, aOR = 1. 29 The remaining aOR estimates were small in magnitude or not statistically significant. As with preterm birth, generally the good-quality studies reported lower estimates than the fair-quality studies for interpregnancy intervals <6 months.
| Perinatal death
Perinatal death was assessed in four cohort studies ( Figure 4A ). 34, 35, 50, 53 The two good-quality studies 34, 35 
| Infant mortality
Infant mortality was assessed in four studies (three cohort studies and one case-control study) ( Figure 4B) . 34 
| D ISCUSS I ON
Among births in high-resource settings, clinically relevant and statistically significant associations between short interpregnancy intervals since last livebirth and perinatal health were supported by some studies, but not all studies. The most consistent evidence of an association was seen for intervals <6 months vs a longer interval (most commonly 18-23 months) and in studies of preterm birth and infant death, less consistent evidence was found for small-forgestational age, while studies of perinatal death showed no relationship. However, the number of studies, precision of estimates and consistency of results varied (Table 2 ). Often, lower quality studies reported higher estimates for short interpregnancy intervals compared with higher quality studies, estimates were attenuated after covariate adjustment, and, within each study, estimates were highest for the shortest interpregnancy interval examined. Most studies examined population-based samples of births, most commonly using U.S. vital records, and many accounted for a similar set of covariates.
Generally the highest quality studies, in terms of internal validity, had limited external generalisability.
Our findings are generally consistent with a previously published 2006 review 2 upon which our systematic review protocol was based.
The previous review also observed an inverse relationship between shorter interpregnancy intervals and adverse perinatal outcomes and an attenuation of estimates after covariate adjustment. The previous review also reported increased adjusted odds of preterm birth and small-for-gestational age birth for interpregnancy intervals <6 months, but found significantly greater risks for these adverse outcomes for interpregnancy intervals up to 17 months. The reviews differ by study aims, methods of study inclusion and data synthesis.
While the 2006 review used statistical meta-analysis to determine combined estimates, we opted against producing a single summary measure due to concerns about study quality and heterogeneity. In addition, we tiered our qualitative synthesis of studies based on our assessment of internal validity and considered both magnitude and statistical significance when synthesising the evidence.
While results of our review support associations between an interpregnancy interval <6 months and some adverse perinatal outcomes, our findings provide less support for intervals of 6-11 months and 12-17 months, particularly for small-for-gestational age, compared with the previous review, and a more recent review of studies from low-and middle-income countries. 66 Our con- Further research conducted among populations at high risk of adverse perinatal outcomes is also needed, as most of the studies conducted to date have been among population-based samples, which can obscure important differences among subgroups. In addition, research is lacking on the effects of interventions aimed at reducing short interpregnancy intervals on subsequent pregnancy outcomes in high-resource settings, although a recently published intervention study from Bangladesh suggests these types of interventions may lead to decreased risk of preterm birth. 68 These types of studies in the U.S. would be useful in targeting health care services.
Limitations of this review include using only English-language articles and restricting the focus to the more commonly studied adverse perinatal health outcomes. Also, our systematic review protocol may have excluded some potentially germane studies, because of our strict inclusion and exclusion criteria. For example, several studies were excluded because they did not adjust for socioeconomic position and/or maternal age, but did investigate the influence of these factors in exploratory analysis 65, [69] [70] [71] [72] [73] or restricted their analysis to certain age groups, thereby controlling for socioeconomic position to some extent. 74 We opted against inclusion of such studies in order to maintain consistency with the previous review. We also excluded otherwise eligible studies that did not provide precision estimates for their measures of effect 24, 26 and those that modelled interpregnancy interval as a continuous, linear variable. [75] [76] [77] In addition, since the publication end date, several relevant studies of interpregnancy intervals and adverse perinatal outcomes from high-resource settings have been published using data from This is the first systematic review of interpregnancy interval and adverse perinatal outcomes restricted to studies from highresource settings, which enhances the applicability of our findings to women in the United States. We present evidence tiered by assessed internal validity quality, helping to highlight the potential role of bias in our current understanding of the evidence base.
Finally, our systematic review is unique, because it includes a number of recently published studies that used maternally linked births to conduct matched sibling comparison analyses, which provide a novel approach to control for confounding by difficult-to-measure characteristics, such as socio-economic position. Inclusion of the findings from these new study designs is critical for enhancing the overall internal validity of the evidence for this topic, though the limited external generalisability of these study cohorts is a concern.
In conclusion, we found that among higher quality studies conducted in high-resource settings, short interpregnancy intervals (<6 or <12 months) are associated with increased risks for preterm birth, small-for-gestational age and infant death, although associations were less consistent in the highest quality studies. It remains unclear whether these associations represent causal effects given the lim- 
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